Table 1.
Characteristic | At Study Entry, TPTD Initiation ± sd |
---|---|
n = 15 | |
Age, y | 39 ± 6 |
BMI, kg/m2 | 21.9 ± 3.9 |
BMD z score | |
LS | −1.9 ± 0.8 |
TH | −1.7 ± 0.5 |
FN | −1.9 ± 0.7 |
Distal radius | 0.1 ± 0.7 |
No. of adult fractures | 2.0 ± 1.8 |
CTXa, ng/mL | 0.319 ± 0.137 |
P1NPb, μg/L | 48 ± 17 |
PTHc, pg/mL | 34 ± 13 |
25 Vit Dd, ng/mL | 41 ± 18 |
Bone biopsy: Cancellous | |
BV/TV, % | 21.3 ± 7.1 |
Bone formation rate, mm2/mm/y | 0.008 ± 0.007 |
Mineral apposition rate, μm/d | 0.64 ± 0.13 |
Mineralized perimeter, % | 3.5 ± 2.8 |
Abbreviations: TPTD, teriparatide.
Normal range, 0–0.700 ng/mL in premenopausal women.
Normal range, 19–83 μg/L in premenopausal women.
Normal range, 14–66 pg/mL.
Normal range > 20–30 ng/mL.